Understanding barriers to healthcare and harm reduction services among women who inject drugs in Nigeria: A qualitative assessment

Women who inject drugs (WID) face barriers to healthcare, harm reduction, and social support, alongside stigma, violence, and legal risk. Evidence from Nigeria remains limited. This study explored how WID experience access to healthcare and harm reduction services and examined the social and structural conditions shaping that access. We used a phenomenological qualitative design in three Nigerian states: Abia, Gombe, and Oyo. Data were collected through 24 key informant interviews and six focus group discussions (FGDs) with WID (10 participants per group). Interview guides explored service availability, preferred access points, perceived quality of care, sexual and reproductive health needs, safety and violence, and barriers to service use. Data were audio-recorded, transcribed, de-identified, and analyzed thematically using ATLAS.ti 24. Four themes were identified: patterns of women’s injecting drug use, access to healthcare and harm reduction services, experiences of gender-based violence, and social and structural barriers. Sterile needles and syringes, HIV and sexually transmitted infection (STI) testing, and some family planning services were reported to be more consistently available through one-stop shops and outreach services, while antenatal care and prevention of mother-to-child transmission (PMTCT) services were mainly accessed through formal health facilities and were less frequently used due to stigma and fear of disclosure. Access through informal drug-use locations (“bunks”) and peer networks was frequently preferred due to convenience, anonymity, and reduced stigma. Improving access for WID requires integration of sexual and reproductive health services within harm reduction platforms, expansion of community-based and outreach delivery models, strengthening of trauma-informed care within health facilities, and establishment of safe and confidential referral systems that reduce exposure to stigma and law enforcement risk.

Authors

Institutions

Publication Details

Journal
PLOS Global Public Health
Published
2026-08-13
DOI
https://doi.org/10.1371/journal.pgph.0007008
Primary Topic
HIV, Drug Use, Sexual Risk
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Understanding barriers to healthcare and harm reduction services among women who inject drugs in Nigeria: A qualitative assessment

Olujide Arije, Jennifer Anyanti, Aisha Dadi, Kene Eruchalu et al.
PLOS Global Public Health
HIV, Drug Use, Sexual Risk
article

Understanding barriers to healthcare and harm reduction services among women who inject drugs in Nigeria: A qualitative assessment

Olujide Arije, Jennifer Anyanti, Aisha Dadi, Kene Eruchalu, Yamen Okonkwo, Peace Ikani, Omokhudu Idogho
article en

Abstract

Women who inject drugs (WID) face barriers to healthcare, harm reduction, and social support, alongside stigma, violence, and legal risk. Evidence from Nigeria remains limited. This study explored how WID experience access to healthcare and harm reduction services and examined the social and structural conditions shaping that access. We used a phenomenological qualitative design in three Nigerian states: Abia, Gombe, and Oyo. Data were collected through 24 key informant interviews and six focus group discussions (FGDs) with WID (10 participants per group). Interview guides explored service availability, preferred access points, perceived quality of care, sexual and reproductive health needs, safety and violence, and barriers to service use. Data were audio-recorded, transcribed, de-identified, and analyzed thematically using ATLAS.ti 24. Four themes were identified: patterns of women’s injecting drug use, access to healthcare and harm reduction services, experiences of gender-based violence, and social and structural barriers. Sterile needles and syringes, HIV and sexually transmitted infection (STI) testing, and some family planning services were reported to be more consistently available through one-stop shops and outreach services, while antenatal care and prevention of mother-to-child transmission (PMTCT) services were mainly accessed through formal health facilities and were less frequently used due to stigma and fear of disclosure. Access through informal drug-use locations (“bunks”) and peer networks was frequently preferred due to convenience, anonymity, and reduced stigma. Improving access for WID requires integration of sexual and reproductive health services within harm reduction platforms, expansion of community-based and outreach delivery models, strengthening of trauma-informed care within health facilities, and establishment of safe and confidential referral systems that reduce exposure to stigma and law enforcement risk.

PLOS Global Public HealthVol. 6(8)
Society for Family Health Nigeria (NG), Obafemi Awolowo University (NG)
ViiV Healthcare
Gender equality
Openalex Percentile: Top 9%
HIV, Drug Use, Sexual Risk
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.